Skip to main content

Latest news

Immunobuddies podcast answers patient's questions about Immunotherapy

A podcast, founded and co-hosted by a Velindre Consultant, has released a miniseries of episodes answering questions on immunotherapy from a patient perspective.

Two people stand by a poster.
Two people stand by a poster.
Velindre oncologists win prestigious international award

Llongyfarchiadau to Dr Ricky Frazer, Dr Senjuti Gupta and the rest of the team behind this prize-winning poster at the European Society for Medical Oncology (ESMO) Congress.

A group of women stand side by side.
A group of women stand side by side.
Success for Cancer Centre nurses at UKONS 2023

The annual UK Oncology Nursing Society (UKONS) Conference 2023 was held at Newport this year and the work of some of our nurses, along with other colleagues, was recognised.

Three polaroid photos are pinned. They show a group of fundraisers, wellbeing boxes, and the front of Velindre Cancer Centre.
Three polaroid photos are pinned. They show a group of fundraisers, wellbeing boxes, and the front of Velindre Cancer Centre.
New initiatives launched for Teenage and Young Adult patients at Velindre

A launch event took place in the family room and it was attended by the fundraisers who helped to raise money for the age-appropriate improvements, which will benefit TYA patients aged 15-24 both in the region and specifically at the ‘Hospital of Hope.’

A group of award winners with their award.
A group of award winners with their award.
Prestigious Macmillan award for the Immunotherapy Toxicity Team

The South East Wales Immunotherapy Toxicity Service took home a Macmillan Professionals Excellence Award last week at the annual ceremony in Glasgow.

Destination 2033 launches

A new strategic plan that will support Velindre University NHS Trust to deliver excellent care, inspirational learning and healthier people has been launched today.

Dr Emma Hudson smiles, alongisde the
Dr Emma Hudson smiles, alongisde the
Velindre proud to be part of successful clinical trial

The results of INTERLACE trial mark the biggest cervical cancer drug advance in 20 years.

Velindre University NHS Trust, Unit 2,Charnwood Court, Parc Nantgarw, Nantgarw, Cardiff, CF15 7QZ
Tel: 029 2019 6161